Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
PainOsteoarthritis
Interventions
PROCEDURE

Canal Block and Capsular Injection

Continuous Adductor canal block with 15-30ml of ropivacaine 0.1% with epinephrine 1:400,000 followed by an infusion of ropivacaine 0.1% at 6 ml per hour for 2 days post operatively. This is combined with ultrasound guided posterior capsular knee injection with 30 ml ropivacaine 0.1% with epinephrine 1:400,000.

PROCEDURE

Femoral with Tibial Nerve Block

Continuous femoral nerve block with 15 ml of ropivacaine 0.1% followed by an infusion of ropivacaine 0.1% at 6 ml per hour for 2 days after surgery combined with tibial nerve block in the popliteal fossa with ropivacaine 0.1% up to 15 ml.

Trial Locations (1)

06105

Saint Francis Hospital and Medical Center, Hartford

All Listed Sponsors
lead

Trinity Health Of New England

OTHER

NCT01805661 - Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement | Biotech Hunter | Biotech Hunter